In a comprehensive review published in “Nature Human Behavior,” researchers evaluated the risks and benefits of screen time for children, revealing significant impacts on their mental health and development.
Ropirio Therapeutics secures exclusive license for novel lymphatic system activators
The Wyss Institute at Harvard University announced today that Ropirio Therapeutics, Inc. (Ropirio) has secured a worldwide, exclusive license from Harvard’s Office of Technology Development